The $1 billion takeover of Vascular Solutions (NSDQ:VASC) by Teleflex (NYSE:TFX) is slated to close today after Vascular Solutions shareholders yesterday approved the deal. The $56-per-share sale brings a portfolio of more than 90 coronary and peripheral vascular devices under the Teleflex umbrella. When the deal was announced last December, Teleflex CEO Benson Smith said that part of the acquisition’s […]
Vascular
Avenu Medical raises $13m
Vascular access system maker Avenu Medical has raised $13.1 million in a new round of equity financing, according to an SEC filing posted this week. The company has not yet stated how it plans to spend funds raised in the round or when it plans to close the round. Money in the round came from 77 unnamed […]
Tryton Medical raises $4m, looks for $4m more in equity round
Tryton Medical raised $4 million in a new round of equity financing, according to an SEC filing posted this week. The Durham, N.C.-based vascular device developer has not yet stated how it plans to spend funds raised or the closing date for the round. Money in the round came from 8 unnamed sources, according to […]
Micro Medical Solutions wins CE Mark for MicroStent BTK vascular stent
Microvascular interventional device dev Micro Medical Solutions said today it won CE Mark approval in the European Union for its MicroStent vascular stent designed for treating patients with peripheral artery disease. The Wilmington, Mass.-based company’s MicroStent is designed to reduce below-the-knee amputations for individuals with PAD resulting in critical limb ischemia. “The MicroStent is the […]
Abbott initiates recall of StarClose SE vascular closure system
Updated to reflect that there were 38 lot numbers identified in the recall, not part numbers. Abbott (NYSE:ABT) said yesterday it initiated an urgent recall of its StarClose SE vascular closure system over issues associated with difficulty or failure to deploy during use. The Chicago, Ill.-based company said that risks associated with the device include prolonged […]
UPDATE: Medtronic wins Health Canada license for drug-coated balloon, touts Japanese data
Medtronic (NYSE:MDT) touted 1 year data from the In.Pact SFA Japan trial of its drug-coated balloon compared to plain balloon angioplasty. The company also said today it won regulatory approval in Canada for its In.Pact Admiral DCB in patients with peripheral artery disease in the upper leg. The trial enrolled 100 patients, 68 of whom […]
Mercator MedSystems touts data for Bullfrog microinfusion device
Mercator MedSystems touted data today from its Dance clinical trial evaluating the company’s Bullfrog micro-infusion device as a delivery system for a generic anti-inflammatory steroid, dexamethasome. Mercator’s results were presented at the International Symposium on Endovascular Therapy and Leipzig Interventional Course. The steroid was delivered to tissues around femoropopliteal arteries after patients underwent endovascular intervention […]
Laminate Medical Technologies raises $8m in Series B
Israeli med device startup Laminate Medical Technologies has raised $8 million Series B financing round to support its VasQ blood vessel support device. The company’s VasQ device is designed to aid kidney failure patients in need of dialysis by providing external support to reduce fistula failure. The VasQ regulates flow by “constraining and shaping optimal […]
Study finds higher complication risk with Cardinal Health’s Mynx vascular closure device
A study published last week in The New England Journal of Medicine concluded that patients treated with Cardinal Health (NYSE:CAH)’s Mynx vascular closure device are at higher risk for vascular complications compared to patients that received alternative vascular closure devices. The data also suggested that patients who received the Mynx device were at greater risk for access site bleeding […]
Avinger touts 2-year Pantheris study data
Avinger (NSDQ:AVGR) today released 2-year interim data from the pivotal Vision trial of its Pantheris system, touting high rates of freedom from target lesion revascularization. The study aimed to analyze the effectiveness of the Pantheris during directional atherectomy procedures, the Redwood City, Calif.-based company said. The Pantheris device is designed to be used to identify vessel lumen […]
Endologix wins CE Mark reinstatement for AFX, AFX2, touts 3-year post market Ovation study
Endologix (NSDQ:ELGX) said today it received notice that the CE Mark approval for its AFX and AFX2 endovascular abdominal aortic aneurysm systems has been reinstated, effective immediately, after being put on hold in early December. The Irvine, Calif.-based company also released 3-year post-market registry data on its Ovation system, designed to treat abdominal aortic aneurysms, touting a […]